Cara Therapeutics, Inc.

NASDAQ: CARA
$15.87
-$0.37 (-2.3%)
Closing price May 29, 2020
Cara Therapeutics shares were crushed on Tuesday after the firm announced results from its midstage trial in patients with chronic kidney disease.
Chris Lange